Belsomra (suvorexant)
Customize your policy alerts
Sign up for Oscar Health Policy PG064 alerts
Get alerted when Policy PG064 changes without checking for updates manually.
Monitor payer policy activity
Oscar Health prior authorization for Belsomra (suvorexant) in adults with insomnia characterized by difficulty with sleep onset and/or sleep maintenance, including initial authorization, reauthorization, documentation, duration, and coverage limitations.
No material clinical or coverage changes in this revision.
Coverage Criteria
Initial Therapy
Covered when ALL of the following initial authorization criteria are met:
ALL of the following
- The member is 18 years of age or older.
- The member has a diagnosis of insomnia characterized by difficulty with sleep onset and/or sleep maintenance.
- Clinical assessment is provided showing that the member has been assessed for concurrent conditions (e.g., anxiety, chronic pain, overactive thyroid) and/or precipitating factors (e.g., certain medicines, caffeine) that are contributing to the insomnia.
- The member has had a trial of psychological and/or behavioral therapy, such as cognitive behavioral therapy for insomnia (CBT-i), stimulus control, psychoeducation/sleep hygiene interventions, sleep-restriction therapy, or relaxation training.
OpenPayer is powered by Trek Health's payer performance platform. Trek continuously ingests, validates, and normalizes Transparency in Coverage data alongside payer policies and other commercial payer data to create a structured payer intelligence foundation. OpenPayer uses this foundation to deliver personalized search results, dynamically generated policy pages, and tailored policy monitoring based on each user's payers, specialties, billing codes, and areas of interest. The same intelligence powers broader payer performance workflows, including reimbursement benchmarking, contract evaluation, payer negotiations, and financial decision-making.